What is the price target for AFX stock?
23 analysts have analysed AFX.DE and the average price target is 34.74 EUR. This implies a price increase of 31.69% is expected in the next year compared to the current price of 26.38.
CARL ZEISS MEDITEC AG - BR (AFX.DE) Forecast, Price Target & Analyst Ratings
FRA:AFX • DE0005313704
Current stock price
26.38 EUR
+0.08 (+0.3%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CARL ZEISS MEDITEC AG - BR (AFX.DE).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 12, 2026
- Period
- Q2 / 2026
- EPS Estimate
- €0.38
- Revenue Estimate
- 533.17M
Price Target Details & History
Consensus Price Target and Range
Mean target
€34.74
Upside
+ 31.69%
From current price of €26.38 to mean target of €34.74, Based on 23 analyst forecasts
Low
€25.25
Median
€31.62
High
€52.50
Price Target Revisions
1 Month
-7.80%
3 Months
-30.21%
Price Target Summary
23 Wall Street analysts provided a forecast for the next 12 months for AFX.DE. The average price target is 34.74 EUR. This implies a price increase of 31.69% is expected in the next year compared to the current price of 26.38.
The average price target has been revised downward by 30.21% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
66.09%
AFX.DE was analyzed by 23 analysts. The buy percentage consensus is at 66. So analysts seem to be have mildly positive about AFX.DE.
In the previous month the buy percentage consensus was at a similar level.
AFX.DE was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-26 | Berenberg | Maintains | Hold -> Hold |
| 2025-12-12 | MWB RESEARCH AG | Maintains | Buy -> Buy |
| 2023-12-20 | EQUI.TS | Downgrade | Buy -> Neutral |
| 2022-12-15 | UBS | Maintains | |
| 2022-11-28 | UBS | Initiate | |
| 2022-10-31 | Deutsche Bank Capital | Initiate | |
| 2022-09-13 | Hauck Aufhäuser Investment Banking | Initiate | |
| 2022-09-13 | Berenberg Capital Markets | Initiate | |
| 2022-07-14 | Hauck Aufhäuser In... | Initiate | |
| 2022-04-21 | Hauck and Aufhaeuser | Initiate | |
| 2022-04-19 | Deutsche Bank Capital | Initiate | |
| 2022-03-16 | UBS | Initiate | |
| 2022-02-14 | HSBC | Initiate | |
| 2022-01-25 | Hauck Aufhäuser La... | Initiate | |
| 2021-12-10 | Kepler Cheuvreux | Initiate | |
| 2021-12-10 | Berenberg Bank | Initiate | |
| 2021-11-01 | Deutsche Bank | Initiate | |
| 2021-08-11 | Nord/LB | Initiate | |
| 2021-07-20 | Hauck & Aufhaeuser | Initiate | |
| 2021-07-20 | Berenberg Bank | Initiate | |
| 2021-07-10 | Hauck & Aufhaeuser | Initiate | |
| 2021-07-09 | Hauck & Aufhaeuser | Initiate | |
| 2021-06-21 | Deutsche Bank | Initiate | Buy |
| 2021-05-26 | Nord/LB | Initiate | Buy |
| 2021-05-26 | Berenberg Bank | Initiate | Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 12, 2026
- Period
- Q2 / 2026
- EPS Estimate
- €0.38
- Revenue Estimate
- 533.17M
- Revenue Q2Q
- -4.79%
- EPS Q2Q
- -26.58%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.03%
EPS (1 Month)
0.00%
EPS (3 Months)
-17.33%
Next Earnings Summary
AFX.DE is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is 0.38 EUR and the consensus revenue estimate is 533.17M EUR.
The next earnings revenue estimate has been revised downward by 0.03% in the past 3 months.
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.089B 9.80% | 2.066B -1.11% | 2.228B 7.82% | 2.236B 0.38% | 2.36B 5.55% | 2.499B 5.89% | 2.669B 6.80% | 2.842B 6.48% | |
| EBITDA YoY % growth | 422.187M -9.53% | 327.223M -22.49% | 349.698M 6.87% | 330.8M -5.40% | 385.24M 16.46% | 428.37M 11.20% | 436.99M 2.01% | 475.22M 8.75% | |
| EBIT YoY % growth | 348.124M -12.28% | 194.452M -44.14% | 223.32M 14.85% | 216.51M -3.05% | 269.65M 24.54% | 297.9M 10.48% | 357.56M 20.03% | 414.06M 15.80% | |
| Operating Margin | 16.66% | 9.41% | 10.02% | 9.68% | 11.43% | 11.92% | 13.40% | 14.57% | |
| EPS YoY % growth | N/A -7.77% | 2.01 -33.76% | 1.61 -19.90% | 1.42 -11.59% | 1.87 31.56% | 2.26 20.55% | 2.75 21.68% | 3.21 17.00% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.38 -26.58% | 0.50 56.31% | 0.69 16.11% |
| Revenue Q2Q % growth | 533.17M -4.79% | 565.66M 2.92% | 655.28M 4.42% |
| EBITDA Q2Q % growth | 58.884M -54.92% | 84.1M -13.48% | 123.17M -37.35% |
| EBIT Q2Q % growth | 33.716M -52.63% | 58.024M 7.53% | 85.728M 22.08% |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
11.93%
EPS Next 5 Year
14.83%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.03%
Revenue Next 5 Year
5.06%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
21.85%
EBIT Next 5 Year
14.95%
CARL ZEISS MEDITEC AG - BR / AFX.DE Forecast FAQ
What is the next earnings date for AFX stock?
CARL ZEISS MEDITEC AG - BR (AFX.DE) will report earnings on 2026-05-12.
What are the consensus estimates for AFX stock next earnings?
The consensus EPS estimate for the next earnings of CARL ZEISS MEDITEC AG - BR (AFX.DE) is 0.38 EUR and the consensus revenue estimate is 533.17M EUR.
Can you provide the consensus rating for CARL ZEISS MEDITEC AG - BR stock?
The consensus rating for CARL ZEISS MEDITEC AG - BR (AFX.DE) is 66.087 / 100 . This indicates that analysts generally have a neutral outlook on the stock.